← Back to Search

Behavioral Intervention

Digital Support Program for Suicide Prevention

N/A
Recruiting
Led By Alejandra Arango
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to week 14
Awards & highlights

Study Summary

This trial studies how effectively an online support system (eYST) helps youth, and looks for feedback from users.

Who is the study for?
This trial is for English-speaking youths who have attempted suicide or are having serious thoughts of harming themselves. They must own a smartphone, be able to understand the study with their guardian's consent, and provide an emergency contact. It excludes those in other treatment studies, unable to follow health safety guidelines like mask-wearing, with conditions that affect informed consent or participation, active psychosis, substance withdrawal issues, or high risk judged by the investigator.Check my eligibility
What is being tested?
The trial is testing the eYST website—an experimental digital platform designed to support young people dealing with suicidal thoughts. The goal is to gather user feedback on eYST and evaluate its effectiveness in aiding these individuals.See study design
What are the potential side effects?
Since this intervention involves using a digital platform rather than medication or medical procedures, traditional side effects are not applicable. However, there may be emotional or psychological impacts from participating in the program which will be monitored.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to week 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to week 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of use of app
Frequency of use of app
System Usability Scale (SUS) score System Usability Scale (SUS)
Secondary outcome measures
Acceptability of Intervention Measure (AIM)
Client Satisfaction Questionnaire (CSQ-I)
Feasibility of Intervention Measure (FIM)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: eYST websiteExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,589 Total Patients Enrolled
112 Trials studying Suicide
1,156,699 Patients Enrolled for Suicide
University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,378,018 Total Patients Enrolled
18 Trials studying Suicide
11,525 Patients Enrolled for Suicide
Patricia SimonStudy DirectorOui Therapeutics, Inc.

Media Library

eYST website (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05900700 — N/A
Suicide Research Study Groups: eYST website
Suicide Clinical Trial 2023: eYST website Highlights & Side Effects. Trial Name: NCT05900700 — N/A
eYST website (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05900700 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the protocol of this trial only pertain to senior citizens?

"As per the standards of this research, only participants aged 13 to 17 may be enrolled."

Answered by AI

Are there any opportunities for prospective patients to participate in this research?

"As per information on clinicaltrials.gov, this trial is no longer enrolling volunteers; its initial posting was July 1st 2023 and the last revision was made June 2nd of that same year. That being said, there are still 180 other trials open to participants at present."

Answered by AI

What qualifications must be met for someone to participate in this research?

"Aspiring enrollees in this medical study must be adolescents aged 13 through 17 who have experienced suicidal ideation. Approximately 120 participants are necessary to complete the trial."

Answered by AI

What is the primary objective of this medical experiment?

"The main outcome of this trial, evaluated over a period of up to 14 weeks, is the frequency with which participants utilise the app. Secondary outcomes include acceptance (measured through Acceptability of Intervention Measure [AIM], scored on a 5-point scale ranging from 1 - 5), appropriateness (Intervention Appropriateness Measure [IAM] also measured on a 5-point scale) and satisfaction (Client Satisfaction Questionnaire [CSQ-I], an 8 item Likert Scale ranging from 8-32)."

Answered by AI
~34 spots leftby Jul 2024